Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013

Pharmaceutical Sales & Brand Management Conference

08 Jul 2013 - 09 Jul 2013 - Las Vegas, NV , USA

Bookmark and Share

How does the pharmaceutical salesperson of the future delivery value?

The answer is no longer simple. What was once a standard operating procedure has been thrown into flux. The market is in the midst of a sea change and pharmaceutical companies are now re-evaluating brand & life cycle management, sales team design & incentives, physician & payer relationships and social media campaigns. Decisions made on these strategic issues will have a direct impact on the organization’s ability to grow as a brand.

However significant change brings new opportunity. The best strategic plans will chart new courses and create new market leaders. Sales teams of the future will solidify new bonds with customers driving brand value. New marketing campaigns will harness the voice of the customer to enhance public awareness. Access will be created by satisfying needs. But only those who understand this dynamic market and develop the best strategic tools will enjoy the successes this new future holds.

GTC’s Pharmaceutical Sales & Brand Management Conference assembles key strategic leaders to discuss and bring clarity to a transitioning market. They will discuss issues, including:
  · Incentivizing sales teams
  · Selling to managed care systems
  · Healthcare reform
  · Market access
  · Social media campaigns
  · Managing specialty drugs
  · Biologic strategies
  · ACOs and their relationships with pharma

This is a unique opportunity to hear from and network with your peers in an exclusive setting devoted entirely to pharmaceutical sales, marketing and brand management.

2013 Pharmaceutical Sales & Brand Management Conference Committee

Conference Advisory Board Members:
Dan Brennan, Vice President, Neurology,
Dan Camardo, Senior Director, Marketing Operations,
 Astellas Pharma US
Frank Dolan, Director, Synergy Sales Force,
 Amylin Pharmaceuticals
Christine Fiore, Compliance Business Partner, Commercial Compliance,
 Boehring Ingelheim
John Grano, Vice President, Global Sales & Marketing Effectiveness,
 Sanofi Pasteur
Kari K. Loeser, Compliance Counsel,
 Jazz Pharmaceuticals
Tom McCann, Vice President, Oncology Sales and Marketing,
 Accredo, a Division of Express Scripts

We look forward to seeing you at the conference!

Further information
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos